A Randomized, Placebo-Controlled, Single and Multiple Ascending-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BMS-791325 in Healthy Japanese Subjects.

Trial Profile

A Randomized, Placebo-Controlled, Single and Multiple Ascending-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BMS-791325 in Healthy Japanese Subjects.

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 17 Jul 2013

At a glance

  • Drugs Beclabuvir (Primary)
  • Indications Hepatitis C
  • Focus Adverse reactions
  • Most Recent Events

    • 17 Jul 2013 Planned end date changed from 1 Jun 2013 to 1 Feb 2015 as reported by ClinicalTrials.gov.
    • 17 Jul 2013 Planned initiation date changed from 1 Feb 2013 to 1 Oct 2014 as reported by ClinicalTrials.gov.
    • 17 Jul 2013 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top